Back
About the Global Fund
Results Report 2021
-
Programs supported by the Global Fund partnership had saved 44 million lives as of the end of 2020. But over the last year, the impact of the COVID-19 pandemic has been devastating.
- Read the online report
People & Structures
Back
Funding Model
Investments & Results
Explore contributions, investments and results in our fight against AIDS, tuberculosis and malaria around the world.
Back
News
-
11 November 2021
United States to Host Next Global Fund Replenishment Conference -
11 November 2021
Lifeline Support from UNDP and the Global Fund Keeps Afghanistan’s Health Facilities Open -
10 November 2021
Global Fund Board Approves New Strategy Placing People and Communities at Center to Lead Fight Against HIV, TB, Malaria, to Build Systems for Health, Equity and Strengthen Pandemic Preparedness
Updates
Stories
Back
Featured Publication
Documents by type
GF/B19/DP18
Approved by the Board on: 06 May 2009
Quality Assurance Review of the Status of Pharmaceutical Products Other than anti-Retroviral, anti-Malaria and anti-Tuberculosis Medicines
The Board requests the Portfolio Committee (PC) to oversee the Secretariat's study of the quality assurance status of pharmaceutical products other than anti-retroviral, anti-malaria and anti-tuberculosis medicines. The Secretariat shall present the findings of the first phase of the study to the PC at its 12th Meeting in September 2009. Based on these findings, the PC may permit the Secretariat to undertake the later stages of the study to explore the possibility of establishing a quality assurance policy for these products. The Board requests the PC to update the Board on the progress of the study at the Board's first meeting in 2010.Budgetary Implications
The budgetary implications of this decision are estimated at approximately US$ 250,000 in 2009 for consultations, meetings and professional fees. The Secretariat will endeavor to absorb the incremental costs in 2009 by making commensurate savings within the already approved budget.
The Global Fund uses cookies for anonymized statistics on website use and content performance to help us improve and adapt the website. To consent to the use of cookies, please click “Accept”. To learn more about your rights and options, please read our Privacy Statement.